Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01016067 · ClinicalTrials.gov registry record · Phase 3
Tibial Delayed Healing Pivotal Clinical Trial
A Phase 3 study, sponsored by Medtronic Spinal and Biologics.
- Terminated
- Registry status
- Phase 3
- Development phase
- 23
- Enrollment target
NCT01016067 is a Phase 3 study that was terminated before completion, run by Medtronic Spinal and Biologics. The registered enrollment target is 23 participants.
The verdict
NCT01016067, a Phase 3 study, was terminated before completion, sponsored by Medtronic Spinal and Biologics.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 23 participants
- Enrollment target
Study Summary
Evaluate the INFUSE/MASTERGRAFT™ Delayed Healing Device as an alternative/replacement to autograft in the treatment of tibial delayed healing.
Interventions
- PROCEDURE Autograft bone
- DEVICE INFUSE/MASTERGRAFT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2010-11 |
| Est. Completion | 2013-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01016067
The ClinicalTrials.gov registry entry for NCT01016067 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Spinal and Biologics, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Autograft bone is the first listed.
NCT01016067 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01016067 about?
NCT01016067 is a clinical study titled "Tibial Delayed Healing Pivotal Clinical Trial". Evaluate the INFUSE/MASTERGRAFT™ Delayed Healing Device as an alternative/replacement to autograft in the treatment of tibial delayed healing.
What is the current status of trial NCT01016067?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 23 participants. The study started on 2010-11. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01016067?
The interventions under investigation include: Autograft bone (PROCEDURE), INFUSE/MASTERGRAFT (DEVICE).
Who is sponsoring clinical trial NCT01016067?
This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.